Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2695 |
|
| Actual shortage: | 246 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2440 (91%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CEFAZOLIN FOR INJECTION | 1G | POWDER FOR SOLUTION | Resolved | 2019-09-26 | 2019-10-10 | 94837 |
| TEVA-TRYPTOPHAN | 1G | TABLET | Resolved | 2020-02-07 | 2020-03-26 | 105564 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2020-03-26 | 2020-08-21 | 109595 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2020-07-23 | 2020-08-21 | 120890 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2020-09-24 | 2020-10-15 | 124995 |
| CEFTRIAXONE SODIUM FOR INJECTION | 1G | POWDER FOR SOLUTION | Resolved | 2021-01-07 | 2021-02-12 | 131093 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2021-04-01 | 2021-04-08 | 136759 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2021-04-29 | 2021-05-13 | 138300 |
| AMPICILLIN SODIUM FOR INJECTION, USP | 1G | POWDER FOR SOLUTION | Resolved | 2021-05-27 | 2021-08-06 | 140036 |
| AMPICILLIN SODIUM FOR INJECTION, USP | 1G | POWDER FOR SOLUTION | Resolved | 2021-06-03 | 2021-08-05 | 140369 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2021-06-17 | 2021-07-22 | 141113 |
| TEVA-TRYPTOPHAN | 1G | TABLET | Resolved | 2021-06-17 | 2021-10-21 | 141119 |
| CEFAZOLIN FOR INJECTION | 1G | POWDER FOR SOLUTION | Resolved | 2021-08-27 | 2021-10-07 | 144733 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2021-08-27 | 2021-09-30 | 144760 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2021-09-30 | 2021-11-05 | 146469 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2021-10-07 | 2021-11-05 | 146856 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2021-12-17 | 2022-01-20 | 151468 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2022-01-27 | 2022-02-25 | 153727 |
| AMPICILLIN SODIUM FOR INJECTION, USP | 1G | POWDER FOR SOLUTION | Resolved | 2022-01-27 | 2022-12-20 | 153739 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2022-06-09 | 2022-09-08 | 162303 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 |